U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7623176231First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable SchizophreniaTerminatedNo Results AvailableSchizophreniaDrug: AMG 579|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01568203
7623276232An Open Trial to Assess the Tolerability of AVANZ Mite Mix ImmunotherapyCompletedNo Results AvailableAllergic Rhinitis Due to Dust MiteBiological: AVANZ MITEhttps://ClinicalTrials.gov/show/NCT01568190
7623376233Cardiac Autonomic Function in Women With Microvascular Coronary DysfunctionRecruitingNo Results AvailableMicrovascular Coronary DysfunctionBehavioral: Mental Stress Testing|Other: Peripheral Arterial Tonometry (PAT) Testing|Other: Heart Rate Variability (HRV)|Other: RESPeRATE Breathing Trial|Procedure: SPECT cardiac scan with 123I-mIBG and Myoviewhttps://ClinicalTrials.gov/show/NCT01568177
7623476234Safety and Efficacy Study of the BioVentrix PliCath HF SystemRecruitingNo Results AvailableHeart FailureDevice: PliCath HF Systemhttps://ClinicalTrials.gov/show/NCT01568164
7623576235Testing Interventions to Motivate and EducateActive, not recruitingNo Results AvailableColorectal CancerBehavioral: Clinic-directed intervention program|Behavioral: Individual Patient-Directed Programhttps://ClinicalTrials.gov/show/NCT01568151
7623676236Prospective Study of the BioVentrix PliCath HFâ„¢ System for the Treatment of Ischemic CardiomyopathyActive, not recruitingNo Results AvailableHeart FailureDevice: PliCath HF Systemhttps://ClinicalTrials.gov/show/NCT01568138
7623776237Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes MellitusActive, not recruitingNo Results AvailableType 2 Diabetes MellitusDrug: Incretin-related drugshttps://ClinicalTrials.gov/show/NCT01568125
7623876238A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal EventsCompletedNo Results AvailableHealthyDrug: BG00012 (dimethyl fumarate)|Drug: BG00012 placebo|Drug: ASA|Drug: ASA placebohttps://ClinicalTrials.gov/show/NCT01568112
7623976239Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseBiological: AFFITOPE® PD01A|Other: Controlhttps://ClinicalTrials.gov/show/NCT01568099
7624076240Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005ATerminatedNo Results AvailableAlzheimer's Diseasehttps://ClinicalTrials.gov/show/NCT01568086
7624176241Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" PhenomenonCompletedHas ResultsParkinson's DiseaseDrug: BIA 9-1067|Drug: Entacapone|Drug: Placebo|Drug: Levodopa|Drug: Carbidopa|Drug: Benserazidehttps://ClinicalTrials.gov/show/NCT01568073
7624276242Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in KoreaRecruitingNo Results AvailableAcellular Pertussis|Diphtheria|Tetanus|PoliomyelitisOther: Infanrix-IPV data collectionhttps://ClinicalTrials.gov/show/NCT01568060
7624376243Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) PatientsCompletedHas ResultsParkinson's DiseaseDrug: Placebo|Drug: BIA 9-1067|Drug: BIA 9-1067|Drug: BIA 9-1067|Drug: Levodopa/Carbidopa|Drug: Levodopa/Benzerazidehttps://ClinicalTrials.gov/show/NCT01568047
7624476244A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067CompletedHas ResultsParkinson's DiseaseDrug: BIA 9-1067|Drug: BIA 9-1067|Drug: BIA 9-1067|Drug: Placebo|Drug: Levodopa/Carbidopa|Drug: Levodopa/Benzerazidehttps://ClinicalTrials.gov/show/NCT01568034
7624576245Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)CompletedHas ResultsRetinal Vein Occlusion|Macular EdemaOther: No Interventionhttps://ClinicalTrials.gov/show/NCT01568021
7624676246Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedHas ResultsOpen-Angle Glaucoma|Ocular HypertensionDrug: Bimatoprost 0.01% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT01568008
7624776247Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and SafetyCompletedNo Results AvailableDermatitis, EczematousDrug: Clobetasone Butyrate 0.05% Cream|Drug: Vehicle (base cream)https://ClinicalTrials.gov/show/NCT01567995
7624876248Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal SymptomsCompletedNo Results AvailableNicotine Withdrawal|Tobacco AbstinenceDevice: tDCS, prefrontal cortex and parietal cortexhttps://ClinicalTrials.gov/show/NCT01567982
7624976249Family Health and Development ProjectActive, not recruitingNo Results AvailableSerious Emotional DisturbanceBehavioral: Intensive In-home Child and Adolescent Psychiatric Service|Behavioral: Home-based Child Treatment Coordinationhttps://ClinicalTrials.gov/show/NCT01567969
7625076250Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability StudyTerminatedNo Results AvailableUlcerative ColitisDrug: Propionyl-L-Carnitine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01567956
7625176251Contingency Management of Alcohol Abuse in the Severely Mentally ILLActive, not recruitingNo Results AvailableAlcohol Abuse|Schizophrenia|Bipolar Disorder|Major Depressive DisorderBehavioral: Contingency Managementhttps://ClinicalTrials.gov/show/NCT01567943
7625276252Temsirolimus as Second-line Therapy in HCCRecruitingNo Results AvailableUnresectable or Metastatic Hepatocellular CarcinomaDrug: Temsirolimushttps://ClinicalTrials.gov/show/NCT01567930
7625376253Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal CancerRecruitingNo Results AvailableSymptomatic Venous Thromboembolism|Asymptomatic Venous ThromboembolismProcedure: CRC surgeryhttps://ClinicalTrials.gov/show/NCT01567917
7625476254Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous LineTerminatedNo Results AvailableThrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)Drug: Semuloparin sodiumhttps://ClinicalTrials.gov/show/NCT01567904
7625576255CT Antigen TCR-redirected T Cells for Ovarian Cancer.RecruitingNo Results AvailableOvarian CancerBiological: NY-ESO-1c259 T cellshttps://ClinicalTrials.gov/show/NCT01567891
7625676256Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health SubjectsCompletedNo Results AvailableSpondylitis, Ankylosinghttps://ClinicalTrials.gov/show/NCT01567878
7625776257Lot-to-lot Consistency Trial of JE Live Attenuated SA 14-14-2 VaccineCompletedNo Results AvailableJapanese EncephalitisBiological: JE live attenuated SA 14-14-2 vaccinehttps://ClinicalTrials.gov/show/NCT01567865
7625876258Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation TimeCompletedHas ResultsPost-anesthesia Recovery|OrientationDrug: Ketamine|Drug: Methohexitalhttps://ClinicalTrials.gov/show/NCT01567852
7625976259Testing the Anesthetic Effectiveness of Three Different Dental Local Anesthetics Injected Next to a Lower First MolarCompletedHas ResultsAnesthetic EffectivenessProcedure: Mandibular buccal Infiltration injectionhttps://ClinicalTrials.gov/show/NCT01567839
7626076260Reduction in YEllow Plaque by Aggressive Lipid LOWering TherapyCompletedNo Results AvailableCoronary Artery DiseaseDrug: standard of care lipid therapy|Drug: Aggressive lipid therapyhttps://ClinicalTrials.gov/show/NCT01567826

* Görseller ve İçerik tekif hakkına sahip olabilir